• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

Dr. Monroe accepts director position at FDA

Article

Scott Monroe, MD, has accepted the position of director of the division of reproductive and urologic products at FDA. Dr. Monroe has served as the acting director of the division since June 2006.

Scott Monroe, MD, has accepted the position of director of the division of reproductive and urologic products at FDA. Dr. Monroe has served as the acting director of the division since June 2006.

His positions in the pharmaceutical industry have included head of the department of reproductive medicine and director of clinical research and medical affairs. Dr. Monroe joined FDA in 2000 as a medical officer in the division of reproductive and urologic products. He was subsequently promoted to medical team leader in 2002, deputy division director in 2005, and acting division director in 2006.

Related Videos
Edward M. Schaeffer, MD, PhD, answers a question during a Zoom video interview
Zhina Sadeghi, MD, answers a question during a video interview
A panel of 4 experts on prostate cancer
A panel of 4 experts on prostate cancer
A panel of 4 experts on prostate cancer
A panel of 4 experts on prostate cancer
A panel of 5 experts on bladder cancer
A panel of 5 experts on bladder cancer
Stephanie Gleicher, MD, answers a question during a Zoom video interview
Related Content
© 2024 MJH Life Sciences

All rights reserved.